|College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer|
ME Hammond, DF Hayes, M Dowsett, DC Allred, KL Hagerty, S Badve, ...
J Clin Oncol 28 (16), 2784-2795, 2010
|Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …|
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Archives of Pathology and Laboratory Medicine 138 (2), 241-256, 2014
|Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes|
U Veronesi, G Paganelli, V Galimberti, G Viale, S Zurrida, M Bedoni, ...
The Lancet 349 (9069), 1864-1867, 1997
|Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013|
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
|A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer|
U Veronesi, G Paganelli, G Viale, A Luini, S Zurrida, V Galimberti, M Intra, ...
New England Journal of Medicine 349 (6), 546-553, 2003
|Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group|
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
|Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015|
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
|Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer|
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
|The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014|
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, ...
Annals of oncology 26 (2), 259-271, 2015
|Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition …|
S Loi, N Sirtaine, F Piette, R Salgado, G Viale, F Van Eenoo, G Rouas, ...
J Clin Oncol 31 (7), 860-867, 2013
|Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series|
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
|Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series|
U Veronesi, G Paganelli, G Viale, V Galimberti, A Luini, S Zurrida, ...
Journal of the national Cancer Institute 91 (4), 368-373, 1999
|Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women …|
P McGale, C Taylor, C Correa, D Cutter, F Duane, M Ewertz, R Gray, ...
Lancet (London, England) 383 (9935), 2127-2135, 2014
|Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells|
M Rimoldi, M Chieppa, V Salucci, F Avogadri, A Sonzogni, GM Sampietro, ...
Nature immunology 6 (5), 507-514, 2005
|Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation|
PB Vermeulen, G Gasparini, SB Fox, M Toi, L Martin, P McCulloch, ...
European Journal of Cancer 32 (14), 2474-2484, 1996
|Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content|
S Pece, D Tosoni, S Confalonieri, G Mazzarol, M Vecchi, S Ronzoni, ...
Cell 140 (1), 62-73, 2010
|Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial|
V Galimberti, BF Cole, S Zurrida, G Viale, A Luini, P Veronesi, P Baratella, ...
The lancet oncology 14 (4), 297-305, 2013
|70-gene signature as an aid to treatment decisions in early-stage breast cancer|
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
|The microtubule-affecting drug paclitaxel has antiangiogenic activity.|
D Belotti, V Vergani, T Drudis, P Borsotti, MR Pitelli, G Viale, R Giavazzi, ...
Clinical Cancer Research 2 (11), 1843-1849, 1996
|Triple-negative breast cancer: disease entity or title of convenience?|
L Carey, E Winer, G Viale, D Cameron, L Gianni
Nature reviews Clinical oncology 7 (12), 683, 2010